MENU
+Compare
OMGA
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$0.55
Change
-$0.02 (-3.51%)
Capitalization
30.4M

OMGA Omega Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
OMGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for OMGA with price predictions
Jan 08, 2025

OMGA in -13.22% downward trend, falling for three consecutive days on January 08, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where OMGA declined for three days, in of 247 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on OMGA as a result. In of 57 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 48 cases where OMGA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for OMGA just turned positive on January 06, 2025. Looking at past instances where OMGA's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where OMGA advanced for three days, in of 160 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.633) is normal, around the industry mean (14.746). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). OMGA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (3.741) is also within normal values, averaging (264.084).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. OMGA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OMGA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
OMGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

OMGA is expected to report earnings to fall 24.43% to -22 cents per share on March 06

Omega Therapeutics OMGA Stock Earnings Reports
Q4'24
Est.
$-0.23
Q3'24
Missed
by $0.04
Q2'24
Beat
by $0.07
Q1'24
Missed
by $0.03
Q4'23
Beat
by $0.08
The last earnings report on November 14 showed earnings per share of -30 cents, missing the estimate of -26 cents. With 204.84K shares outstanding, the current market capitalization sits at 30.40M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
140 First Street
Phone
+1 617 949-4360
Employees
94
Web
https://www.omegatherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NRGV2.030.12
+6.28%
Energy Vault Holdings
DOLE13.230.26
+2.00%
Dole plc
BCAB0.490.01
+1.46%
BioAtla
DD77.470.81
+1.06%
DuPont de Nemours
SKYW109.290.32
+0.29%
SkyWest

OMGA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OMGA has been loosely correlated with PRME. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if OMGA jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OMGA
1D Price
Change %
OMGA100%
-3.04%
PRME - OMGA
45%
Loosely correlated
+0.70%
MDGL - OMGA
44%
Loosely correlated
+7.64%
ATXI - OMGA
40%
Loosely correlated
+5.71%
RXRX - OMGA
39%
Loosely correlated
+2.03%
ABOS - OMGA
38%
Loosely correlated
+2.48%
More